H.R. 6133
Referred to CommitteeInforming Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
Introduced 6/19/2018•115th Congress•House
Latest Action
Referred to the House Committee on Energy and Commerce.
6/19/2018 • House
Summary
Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
This bill requires the Food and Drug Administration to develop evidence-based opioid prescribing guidelines for certain acute pain treatment.
Introduced in House • 6/19/2018
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationDrug therapyDrug trafficking and controlled substancesFood and Drug Administration (FDA)Government studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive carePrescription drugsPublic participation and lobbyingRetail and wholesale trades
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (1)
Sponsor
R[
No cosponsors yet
Cosponsors may be added as the bill moves through Congress
Bill Journey
Originated in the House
Introduced
June 19, 2018
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House6/19/2018